Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2003
05/22/2003US20030097679 Production of ascorbic acid in plants
05/22/2003US20030097678 Cultivating a transgenic dicotyledonous plant having an expression system inducible during the germination; placing transgenic dicotyledonous seeds comprising expression system integrated into plant genome in medium to germinate
05/22/2003US20030097677 Transgenic high tryptophan plants
05/22/2003US20030097676 Plant acyl-CoA synthetases
05/22/2003US20030097675 Cell cycle stress-related proteins and methods of use in plants
05/22/2003US20030097673 Enhanced accumulation of trehalose in plants
05/22/2003US20030097672 Transforming plant cell with a nucleic acid construct containing a polynucleotide encoding gai gene, regulatory sequence, and transcription termination sequence; regenerating plant from plant cell; expression of gai gene inhibits pollen
05/22/2003US20030097671 Inhibition of betaarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia
05/22/2003US20030097670 For producing and isolating homogeneous proteins
05/22/2003US20030097669 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of Erk-5
05/22/2003US20030097668 Compositions and methods for the treatment and diagnosis of cardiovascular disease
05/22/2003US20030097667 For therapy of Alzheimers disease, diagnosis
05/22/2003US20030097665 To produce phosphorylated lysosomal proteins which are incorporated into pharmaceutical formulations for use in enzyme replacement therapy
05/22/2003US20030096987 Nucleic acid-bondable magnetic carrier and method for isolating nucleic acid using the same
05/22/2003US20030096985 Small and cysteine rich antifungal defensin and thionin-like protein genes highly expressed in the incompatible interaction
05/22/2003US20030096982 Nucleotide sequences coding polypeptide for use in the treatment of immunological, reproductive and liver disorders
05/22/2003US20030096973 Recombinant collagens and derived proteins produced by plants, methods of obtaining such and their uses
05/22/2003US20030096964 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/22/2003US20030096958 Polypeptide for use in the treatment of cancer and kidney disorders
05/22/2003US20030096956 Process for producing kiss-1 peptide
05/22/2003US20030096953 Protein mixture for use in the detection of microbiocides
05/22/2003US20030096947 Placental organic anion transporter and gene thereof
05/22/2003US20030096816 Such as 2-methylsulfanyl-5-(2-phenylamino-pyrimidin-4-yl)-4-p-tolyl-thiophene-3 -carbonitrile; antiproliferative agents; stents
05/22/2003US20030096787 Comprising the ITR sequences, a sequence permitting the encapsulation, a heterologous DNA sequence, and in which the E1 gene and at least one of the E2, E4 and L1-L5 genes is non-functional
05/22/2003US20030096784 Oligoribonucleotides and oligoribonucleosides that have subsequences of 2'-pentoribofuranosyl nucleosides that activate dsRNase (double stranded RNAase)
05/22/2003US20030096783 21132, a human G-protein coupled receptor family member and uses therefor
05/22/2003US20030096782 Expression profiling in the intact human heart
05/22/2003US20030096781 Interleukin-8 (IL-8); antisense nucleotide targeted to IL-8 for rapid treatment without the associated cumulative toxicity of conventional treatments
05/22/2003US20030096780 High affinity IP3-binding polypeptide
05/22/2003US20030096779 High molecular weight Dermatophagoides proteins, and nucleic acids encoding them; used to treat and diagnose mite allergies
05/22/2003US20030096777 Antisense oligonucleotides which inhibit expression of a gene in operable association with protein effectors of that gene's product; DNA methyltransferase is inhibited at the genetic level as well as at the protein level; antitumor
05/22/2003US20030096776 Inhibiting the division of a malignant mammalian cell and for modulating the effects of cellular aging
05/22/2003US20030096775 Treating multiple sclerosis, infection, or atherosclerosis
05/22/2003US20030096774 Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same
05/22/2003US20030096773 Antisense modulation of acyl coenzyme a cholesterol acyltransferase-1 expression
05/22/2003US20030096772 Antisense modulation of acyl CoA cholesterol acyltransferase-2 expression
05/22/2003US20030096771 8-50 nucleobases targeted to a nucleic acid molecule encoding hormone-sensitive lipase to hybridize with and inhibit expression
05/22/2003US20030096769 Genetic molecules capable of modulating growth factor interaction with its receptor on epidermal keratinocytes
05/22/2003US20030096768 Treating the cell with a Receptor Internalization and Degradation (RID) protein complex; antitumor agents; treating degenerative and immune disorders
05/22/2003US20030096767 Strategy for suppressing the expression of an endogeneous gene by using compounds that are able to bind to the non-coding regions of the gene to be suppressed
05/22/2003US20030096765 Aromatic esters; cytotoxic agents; antitumor agents
05/22/2003US20030096756 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/22/2003US20030096754 Vascular endothelial growth factor variants
05/22/2003US20030096752 Net charge of -3-3 at pH 7 and with the amino acids arginine15 or arginine15-alanine17 in the binding region; serine protease inhibitors
05/22/2003US20030096751 G-protein coupled receptor polynucleotides and methods of use thereof
05/22/2003US20030096749 Human cytokine receptor
05/22/2003US20030096746 Compounds and methods for inhibiting cancer metastasis
05/22/2003US20030096739 Nuclear receptor-mediated introduction of a PNA into cell nuclei
05/22/2003US20030096738 Peptide vector
05/22/2003US20030096732 Regulating gene expression of telomerase reverse transcriptase (TERT); therapeutic agent screening applications
05/22/2003US20030096416 Gene which exhibits induced expression by stress
05/22/2003US20030096415 Infection with chimaeric adenoviruses of cells negative for the adenovirus serotype 5 Coxsacki adenovirus receptor (CAR)
05/22/2003US20030096414 Culture medium for cell growth and transfection
05/22/2003US20030096399 Enzymatic nucleotide sequence pool for use as tool in analysis of gene expression
05/22/2003US20030096398 Artificial nucleotide sequences for use as tools in gene therapy
05/22/2003US20030096397 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
05/22/2003US20030096393 Polypeptide for use in the treatment of alzheimers's, tumor, multiple sclerosis, congestive heart failure, schemic reperfusion, blood and thrombotic disorders
05/22/2003US20030096392 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
05/22/2003US20030096390 Novel lipase genes
05/22/2003US20030096388 Proteinase inhibitor, precursor thereof and genetic sequences encoding same
05/22/2003US20030096386 Nuclelotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorder
05/22/2003US20030096381 Production of polyketides
05/22/2003US20030096370 Gram negative bacterial protein for use in the prevention and treatment of bacterial infection
05/22/2003US20030096369 Non-anaphylactogenic IgE vaccines
05/22/2003US20030096368 Nucleotide sequences coding bactericide for use in the treatment and prevention of neisseria infections
05/22/2003US20030096367 Protein for use in the treatment of cell proliferative, autoimmune and nervous system disorders
05/22/2003US20030096365 Biochemical and genetic characterization of propionicin T1
05/22/2003US20030096362 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096360 Cloned peripheral nerve, tetrodotoxin-resistant sodium channel alpha-subunit
05/22/2003US20030096359 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096358 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096357 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/22/2003US20030096356 G protein-coupled receptor protein for use in the diagnosis and treatment of alzheimer's disease
05/22/2003US20030096354 Synthetic polypeptide ligand for use in the treatment of cardiovascular, tumor, viral and hypertensive disorders
05/22/2003US20030096352 Nucleotide sequences coding polypeptides for use in the treatment and prevention of viral and bacterial disease
05/22/2003US20030096350 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/22/2003US20030096349 N4 virion single-stranded DNA dependent RNA polymerase
05/22/2003US20030096348 DNA molecules encoding mammalian nuclear receptor protein, nNR5
05/22/2003US20030096344 Therapeutic agent for use in the diagnosis and treatment of cancer and cell proliferative disorders
05/22/2003US20030096343 Modular assembly of antibody genes, antibodies prepared thereby and use
05/22/2003US20030096341 Generation of preferential enzymatic polypeptide in eukaryote; obtain vector, minsert clone, transfrom eukaryotic cell, expres vector, purify polypeptide
05/22/2003US20030096338 Protein conjugate for use in the treatment of blood disorder
05/22/2003US20030096336 Insect sodium channels from insecticide-susceptible and insecticide-resistant house flies
05/22/2003US20030096335 Nucleic acid fragment and vector comprising a halogenase, and a process for halogenating chemical compounds
05/22/2003US20030096329 (1-3)-beta-D-glucan binding domain protein, measuring method using the substance and assay kit
05/22/2003US20030096323 Detecting phosphodiesterase inhibitor; obtain cell, incubate with modulator, monitor expression of cyclic adenine and guanine monophosphates, compare to control, reduction in concentrations indicate inhibitor
05/22/2003US20030096322 System for cell-based screening
05/22/2003US20030096319 Method of sorting birds
05/22/2003US20030096318 Detection of cell preferential protein expression; obtain cells, monitor protein expression pattern, compare to control, detect expression of unique proteins
05/22/2003US20030096313 Novel serine-threonine kinase-4
05/22/2003US20030096312 Novel natrium-calcium exchanger protein
05/22/2003US20030096306 Intrabodies with defined framework that is stable in a reducing environment and applications thereof
05/22/2003US20030096299 Natural ligand of G protein coupled receptor ChemR23 and uses thereof
05/22/2003US20030096297 Method for identifying inhibitors of G protein coupled receptor signaling
05/22/2003US20030096296 Detect compound which binds to bone morphogenic protein receptors; obtain sample, incubate with binding agent, allow binding, detect complex formation between binding agent and receptors
05/22/2003US20030096292 Method of making high density arrays
05/22/2003US20030096291 Multiplex oligonucleotide addition and target amplification
05/22/2003US20030096289 Oligonucleotide-immobilized substrate for detecting methylation
05/22/2003US20030096288 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders
05/22/2003US20030096287 Oligonucleotide for use as diagnostic tool in genetic engineering
1 ... 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 ... 4023